Variation of Proteolytic Cleavage Sites towards the N-Terminal End of the S2 Subunit of the Novel SARS-CoV-2 Omicron Sublineage BA.2.12.1.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
08 Sep 2022
Historique:
received: 11 08 2022
revised: 04 09 2022
accepted: 05 09 2022
entrez: 23 9 2022
pubmed: 24 9 2022
medline: 28 9 2022
Statut: epublish

Résumé

The prevalence of novel SARS-CoV-2 variants is also accompanied by an increased turnover rate and additional cleavage sites at the positions necessary for priming the Spike (S) protein. Of these priming sites, the proteolytically sensitive polybasic sequence of the activation loop at the S1/S2 interface and the S2' location within the S2 subunit of the S protein are cleaved by furin and TMPRSS2, which are important for the infection of the target cell. Neutrophils, migrating to the site of infection, secrete serine proteases to fight against pathogens. The serine proteases encompass neutrophil elastase (NE), proteinase 3 (PR3), and cathepsin G (CatG), which can hydrolyze the peptide bond adjacent to the S1/S2 interface. SARS-CoV-2 might take the opportunity to hijack proteases from an immune response to support viral entry to the cell. The region near S704L within the S2 subunit, a novel amino acid substitution of SARS-CoV-2 Omicron sublineage BA.2.12.1, is located close to the S1/S2 interface. We found that NE, PR3, and CatG digested the peptide within this region; however, the S704L amino acid substitution altered cleavage sites for PR3. In conclusion, such an amino acid substitution modifies S2 antigen processing and might further impact the major histocompatibility complex (MHC) binding and T cell activation.

Identifiants

pubmed: 36144551
pii: molecules27185817
doi: 10.3390/molecules27185817
pmc: PMC9506045
pii:
doi:

Substances chimiques

Peptides 0
Spike Glycoprotein, Coronavirus 0
spike protein, SARS-CoV-2 0
Peptide Hydrolases EC 3.4.-
Cathepsin G EC 3.4.21.20
Leukocyte Elastase EC 3.4.21.37
Furin EC 3.4.21.75
Myeloblastin EC 3.4.21.76

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Nazarbayev University
ID : 280720FD1907.

Références

Front Mol Biosci. 2021 Apr 13;8:629873
pubmed: 33928117
PLoS One. 2022 Apr 18;17(4):e0264723
pubmed: 35436320
Int J Mol Sci. 2016 Nov 25;17(12):
pubmed: 27898009
Nature. 2022 Aug;608(7923):593-602
pubmed: 35714668
Nat Med. 2021 May;27(5):759-761
pubmed: 33972793
Arch Virol. 2022 Feb;167(2):327-344
pubmed: 35089389
Science. 2022 Aug 12;377(6607):728-735
pubmed: 35857439
Cell Rep. 2022 May 17;39(7):110829
pubmed: 35550680
iScience. 2020 Jun 26;23(6):101212
pubmed: 32512386
Nucleic Acids Res. 2021 Jul 2;49(W1):W216-W227
pubmed: 33849055
N Engl J Med. 2022 Jul 7;387(1):86-88
pubmed: 35731894
Sci Adv. 2022 Apr 29;8(17):eabl5394
pubmed: 35486722
PLoS One. 2020 Oct 20;15(10):e0240012
pubmed: 33079950
Biomed Pharmacother. 2022 Oct;154:113522
pubmed: 36030585
Nat Rev Mol Cell Biol. 2022 Jan;23(1):3-20
pubmed: 34611326
Pharmacol Rev. 2010 Dec;62(4):726-59
pubmed: 21079042
Microbiol Immunol. 2022 Jan;66(1):15-23
pubmed: 34561887
ACS Omega. 2021 Mar 05;6(10):7181-7185
pubmed: 33748632

Auteurs

Nadine Anna Schilling (NA)

Faculty of Organic Chemistry, Eberhard Karls University Tübingen, 72076 Tübingen, Germany.

Hubert Kalbacher (H)

Institute of Clinical Anatomy and Cell Analysis, Faculty of Medicine, Eberhard Karls University Tübingen, Österbergstraße 3, 72074 Tübingen, Germany.

Timo Burster (T)

Department of Biology, School of Sciences and Humanities, Nazarbayev University, Kabanbay Batyr Ave. 53, Nur-Sultan 010000, Kazakhstan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH